Long term efficacy and safety of Ledipasvir and Sofosbuvir in patients with hepatitis C virus related cryoglobulinaemia without renal involvement

Trial Profile

Long term efficacy and safety of Ledipasvir and Sofosbuvir in patients with hepatitis C virus related cryoglobulinaemia without renal involvement

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2018

At a glance

  • Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Feb 2018 New trial record
    • 13 Feb 2018 Results published in the Clinical and Experimental Rheumatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top